Clinical Research Directory
Browse clinical research sites, groups, and studies.
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
Sponsor: Centre Hospitalier Universitaire de Nice
Summary
Recent data suggest involvement of Acid-Sensing Ion Channel channels in the pathophysiology of migraine making these channels a therapeutic target of migraine disease. The implication of Acid-Sensing Ion Channels is discussed through Acid-Sensing Ion Channel-1 which is the most expressed Acid-Sensing Ion Channel channel subtype in the central nervous system. In a mouse model, cortical spreading depression is inhibited by different Acid-Sensing Ion Channel blockers including amiloride which is a non-selective blocker of the Acid-Sensing Ion Channel-1 channel. From a translational perspective, an efficacy of amiloride on a series of migraine patients suffering from severe aura in open conditions. The APAM study is a proof-of-concept study that aims to evaluate the effect of amiloride in the prophylaxis of migraine with aura. This is a randomized crossover study versus placebo conducted in 3 French headache centers.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2020-08-11
Completion Date
2027-12
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Interventions
Amiloride
Treatment by Amiloride vs placebo in crossover
Placebos
Treatment by Amiloride vs placebo in crossover
Locations (5)
Hôpital Pierre Wertheimer
Bron, France
CHU Gabriel Montpied
Clermont-Ferrand, France
AP-HM
Marly, France
CHU de Montpellier
Montpellier, France
CHU de NICE
Nice, France